Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials
Year: 2024
Type: article
Source: Circulation
Institutions: Brigham and Women's Hospital, Harvard University, Royal North Shore Hospital, UNSW Sydney, The George Institute for Global Health, The University of Sydney, National Health and Medical Research Council, University of Groningen, Stanford Medicine, Stanford University, University of Glasgow
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Auris Health
OpenAlex ID: W4396831714